Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Baricitinib may help people with long-term alopecia areata.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Clonally expanded CD8+ T cells cause alopecia areata.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

A woman was wrongly diagnosed with lupus but actually had leprosy.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

CCCA may be caused by both hair traction and an immune response.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

The girl's skin condition is benign but challenging to treat due to its size and location.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.